Former 23andMe CEO Anne Wojcicki now runs TTAM Research Institute, which outbid Regeneron in an auction for the bankrupt company’s assets.

That means Wojcicki’s nonprofit TTAM Research Institute will purchase “substantially all” of San Francisco-based 23andMe’s assets for $305 million. The transaction — which arrives more than three ...

Anne Wojcicki on genetic privacy, data security, her bid for 23andMe Why California wants to stop 23andMe's sale to former ...

Anne Wojcicki, co-founder and former CEO of 23andMe, will regain control of the embattled genetic testing company through a $305 million acquisition by her nonprofit TTAM Research Institute, the ...

A nonprofit run by Anne Wojcicki, the cofounder and former CEO of 23andme, ... For a long time, it appeared Wojcicki wouldn’t regain control of the company she left in March.

In a surprise twist, 23andMe founder and former CEO Anne Wojcicki is set to regain control of the DNA company's assets, according to a press release from 23andMe. In May, a company called Regeneron ...

(Reuters) -Anne Wojcicki is set to regain control of 23andMe after a nonprofit she controls topped Regeneron Pharmaceuticals' bid for the DNA-testing company for $305 million as part of a ...

Anne Wojcicki, the co-founder and former CEO of 23andMe MEHCQ-0.32%decrease; red down pointing triangle, is poised to regain control of the DNA-testing company after a nonprofit she controls ...

23andMe co-founder and former CEO Anne Wojcicki is set to buy back the company through a nonprofit public benefit corporation, TTAM Research Institute.

Months after 23andMe CEO Anne Wojcicki publicly stated she wants to take the company she co-founded private, all of the company’s independent board directors have resigned. The board letter to ...

A court has approved the $305m sale of 23andMe’s assets to a nonprofit led by its former CEO Anne Wojcicki, effectively putting her back in control of the bankrupt genetics company.